Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer (Q40778365)

23 September 2017

Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer (English)

1 reference

23 September 2017

1 reference

Walker LG

1

1 reference

23 September 2017

Heys SD

2

1 reference

23 September 2017

Walker MB

3

1 reference

23 September 2017

Ogston K

4

1 reference

23 September 2017

Miller ID

5

1 reference

23 September 2017

Hutcheon AW

6

1 reference

23 September 2017

Sarkar TK

7

1 reference

23 September 2017

Ah-See AK

8

1 reference

23 September 2017

Eremin O

9

1 reference

23 September 2017

language of work or name

1 reference

1 December 1999

1 reference

European Journal of Cancer

23 September 2017

1 reference

23 September 2017

35

1 reference

23 September 2017

13

1 reference

23 September 2017

1783-1788

1 reference

The management of locally advanced breast cancer

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Quality-of-life assessment: performance status upstaged?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Quality of life of cancer patients at different stages in the disease trajectory

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

A daily diary for quality of life measurement in advanced breast cancer trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Carcinoma of the breast: measurement and the management of treatment. I. The value of the data.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Survival of breast cancer patients receiving adjunctive psychosocial support therapy: a 10-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Effects of counseling for late stage cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Length of survival and lymphocyte percentage in women with mammary cancer as a function of psychotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

The effect of compliance with treatment on survival among patients with hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Surviving cancer: do psychosocial factors count?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900169-0

7 January 2021

10.1016/S0959-8049(99)00169-0

Identifiers

DOI

1 reference

23 September 2017

1 reference